European Investor
21 Apr 2026, 19:02
Johnson & Johnson unveiled new advancements in its electrophysiology portfolio at the Heart Rhythm Society (HRS) 2026 meeting, including the launch of the AI-powered CARTOSOUND SONATA module. The new technology enhances cardiac imaging and mapping by automatically converting intracardiac ultrasound data into detailed heart models, improving precision in treating arrhythmias.
The innovation integrates with existing CARTO systems and supports procedures for conditions such as atrial fibrillation and ventricular tachycardia. The company also presented new clinical data on its VARIPULSE platform, highlighting improved safety, efficiency, and real-world patient outcomes in pulsed field ablation therapies.
Marking 30 years of the CARTO system, Johnson & Johnson emphasized its continued focus on AI-driven innovation to advance cardiac care and improve treatment outcomes for heart rhythm disorders.
Business Wire
The innovation integrates with existing CARTO systems and supports procedures for conditions such as atrial fibrillation and ventricular tachycardia. The company also presented new clinical data on its VARIPULSE platform, highlighting improved safety, efficiency, and real-world patient outcomes in pulsed field ablation therapies.
Marking 30 years of the CARTO system, Johnson & Johnson emphasized its continued focus on AI-driven innovation to advance cardiac care and improve treatment outcomes for heart rhythm disorders.
Business Wire